PPARG and cancer: Notwithstanding a pleiotropic role in cancer, which appears type and tumor microenvironment (TME)-dependent, increasing evidence is demonstrating that PPAR-γ can modulate carcinogenesis, showing promise as a focus for cancer therapies.